TIME COURSE OF VARIOUS INFLAMMATORY MEDIATORS DURING RECURRENT ENDOTOXEMIA

被引:74
作者
KLOSTERHALFEN, B [1 ]
HORSTMANNJUNGEMANN, K [1 ]
VOGEL, P [1 ]
FLOHE, S [1 ]
OFFNER, F [1 ]
KIRKPATRICK, CJ [1 ]
HEINRICH, PC [1 ]
机构
[1] RHEIN WESTFAL TH AACHEN,DEPT BIOCHEM,W-5100 AACHEN,GERMANY
关键词
D O I
10.1016/0006-2952(92)90167-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The time course of thromboxane B2 (TxB2), 6-keto-PGF1alpha (stable metabolite of prostacyclin), tumor necrosis factor-alpha (TNF(alpha)), platelet activating factor (PAF), and interleukin-6 (IL-6) formation after three lipopolysaccharide (LPS) infusions was studied in pigs over an 18-hr, period. The Escherichia coli endotoxin W0111:B4 was injected i.v. into 10 of the test group pigs at a dose of 0.5-mu-g/kg over 30 min at 0, 5 and 10 hr of the experiment. Three pigs injected with physiological saline served as controls. At defined time points before and after each LPS administration venous blood was withdrawn (0, 15, 30, 45, 60, 120, 180 min) and plasma levels of TxB2, 6-keto-PGF1-alpha, PAF, TNF(alpha) and IL-6 were determined. Pulmonary artery pressure (PAP) and cardiac output (CO) were measured every 15 min. TxB2 and PAF peaked significantly between 30 and 45 min, TNF(alpha) and 6-keto-PGF1-alpha between 30 and 60 min, and IL-6 between 120 and 180 min after each LPS injection. The mediators PAF, TNF(alpha) and TxB2 showed a decreasing three-peak profile whereas 6-keto-PGF1-alpha exhibited an increasing one. IL-6 plasma concentrations increased after each LPS injection. The peak after the third LPS administration, however, was surprisingly low compared to the previous two. The first LPS infusion in our test group led to a significant, sustained rise in mean PAP. After recurrent LPS injections the peak in PAP was not as marked as after the first infusion, indicating the development of a tolerance towards LPS. Initially, CO showed hypodynamic values, whereas the end stage of the experiment was characterized by hyperdynamic CO levels. In conclusion, we believe this porcine model of septic shock to be one of the first large animal models to describe in detail the time-course of various important inflammatory mediators.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 57 条
  • [1] PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES
    AARDEN, LA
    DEGROOT, ER
    SCHAAP, OL
    LANSDORP, PM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) : 1411 - 1416
  • [2] ADERKA D, 1989, J IMMUNOL, V143, P3517
  • [3] PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN
    BEUTLER, B
    MILSARK, IW
    CERAMI, AC
    [J]. SCIENCE, 1985, 229 (4716) : 869 - 871
  • [4] CIRCULATING INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR IN SEPTIC SHOCK AND EXPERIMENTAL ENDOTOXIN FEVER
    CANNON, JG
    TOMPKINS, RG
    GELFAND, JA
    MICHIE, HR
    STANFORD, GG
    VANDERMEER, JWM
    ENDRES, S
    LONNEMANN, G
    CORSETTI, J
    CHERNOW, B
    WILMORE, DW
    WOLFF, SM
    BURKE, JF
    DINARELLO, CA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) : 79 - 84
  • [5] PLATELET-ACTIVATING-FACTOR MEDIATES HEMODYNAMIC-CHANGES AND LUNG INJURY IN ENDOTOXIN-TREATED RATS
    CHANG, SW
    FEDDERSEN, CO
    HENSON, PM
    VOELKEL, NF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (05) : 1498 - 1509
  • [6] CHARD T, 1987, LABORATORY TECHNIQUE, V6
  • [7] PRETREATMENT WITH RECOMBINANT MURINE TUMOR NECROSIS FACTOR ALPHA-CACHECTIN AND MURINE INTERLEUKIN-1 ALPHA PROTECTS MICE FROM LETHAL BACTERIAL-INFECTION
    CROSS, AS
    SADOFF, JC
    KELLY, N
    BERNTON, E
    GEMSKI, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) : 2021 - 2027
  • [8] RELATIONSHIP BETWEEN LUNG INJURY AND LUNG LIPID-PEROXIDATION CAUSED BY RECURRENT ENDOTOXEMIA
    DEMLING, R
    LALONDE, C
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (05): : 1118 - 1124
  • [9] PULMONARY INJURY AND PROSTAGLANDIN PRODUCTION DURING ENDOTOXEMIA IN CONSCIOUS SHEEP
    DEMLING, RH
    SMITH, M
    GUNTHER, R
    FLYNN, JT
    GEE, MH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1981, 240 (03): : H348 - H353
  • [10] DEMLING RH, 1986, SURGERY, V100, P876